Measuring the impact of the environment in developing mental health disorders: highlighting innovation in methodology

Rachel Upthegrove,Paola Dazzan,David Ryan,Zuzanna Zajkowska,Alexander Murray

DOI: https://doi.org/10.1016/j.psyneuen.2023.106778

IF: 4.693

2024-02-01

Psychoneuroendocrinology

Abstract:Driving factors for the development of major mental illness include genetic risk, but equally important are environmental experiences that can give intersectional and potentially modifiable risks- such as deprivation, minority status, bullying. Much more work needs to be done to develop our mechanistic understanding on how these adverse events lead to mental illness, to allow targeted treatments, and effective intervention in mental health disorders requires the accurate identification of those at risk in earliest stages of developing disorder. Thus it is essential that studies are representative of people at risk, and include the most useful and mechanistically relevant biomarkers. The methods used to best gather this represetnative data, and how to model complexity within representative data, is the current challenge. Research into how to engage children and young people from representative groups into biological research lacking. The CELEBRATE project (Co-producing a framework of guiding principles for Engaging representative and diverse cohorts of young peopLE in Biological ReseArch in menTal hEalth) aims to address this challenge and is working with parents and teachers, to develop a “Framework of Guiding Principles” that will give researchers interested in studying biology and mental health in young people tools to best approach research, what makes them interested to stay involved, what roles they would like to play in the research team, and what benefits they would like to see from taking part. This symposia will highlight existing work from partners within the CELEBRATE project, setting the scene for the challenge and opportunities that will be addressed in the project. We include project outputs focused on 1) inflammation in adolescent depression in the context of childhood trauma, with data from South America; 2) inflammatory biomarkers measures in young people with internalising symptoms and childhood adversity in South London; 3) vitamin-D measured in a representative cohort of children in Bradford, England 4) finally we will present novel data science methods for modelling neuroinflammatory signals in complex multi-site trial data highlighting solutions to data complexity. We hope the symposia will be of interest to a wide audience, including both method and content of cutting edge reserach projects, engaging a wide discussion on challenges and opportunities in the acquisition of representative biomarker data in children and young people.

neurosciences,endocrinology & metabolism,psychiatry